Functional Endoscopic Sinus Surgery Market Size, Share & Trends by Product (Endoscopes (Sinuscopes, Rhinoscopes), Surgical Instruments, Navigation Systems), Procedure (Maxillary, Ethmoid), Indication (Chronic Sinusitis, Nasal Polyposis), Patient type - Global Forecast to 2029
Report Code: MD 9094 Jul, 2024, by marketsandmarkets.com
Functional Endoscopic Sinus Surgery Market Size, Share & Trends
The size of global functional endoscopic sinus surgery market in terms of revenue was estimated to be worth $1.2 billion in 2024 and is poised to reach $1.7 billion by 2029, growing at a CAGR of 7.6% from 2024 to 2029. The growth in this market is due to a significant shift towards minimally invasive, in-office surgery which is a more patient-friendly substitute. This has an added advantage over traditional procedures, for instance, less anaesthesia, more convenient, faster turn around times, and at reduced costs. Additionally, innovations in surgical techniques have emerged in MIS procedures like robotic-assisted surgeries which will offer improved precision and less tissue trauma. However, the shortage of skilled professionals and availability of non-surgical substitutes likely to restrain the market.
Functional Endoscopic Sinus Surgery Market Trends
To know about the assumptions considered for the study, Request for Free Sample Report
Functional endoscopic sinus surgery Dynamics
DRIVER: High prevalence of chronic sinusitis
Sinusitis is a condition where the sinuses are inflamed for over twelve weeks. Chronic sinusitis can result from infections, nasal polyps, or sinus lining swelling. The American Academy of Allergy Asthma and Immunology (December 2023) states that about 20% of chronic rhinosinusitis (CRS) patients have nasal polyps. CRS is common, potentially affecting 1 in 8 people, and costs the US between USD 10-13 billion directly and over USD 20 billion indirectly each year.
RESTRAINT: Availability of non-surgical treatment
Chronic sinusitis causes inflammation of the nasal sinuses lasting 12 weeks or more and is one of the most common chronic conditions in the US. It's typically treated with medication, but surgery is needed for recurrent or persistent infections. Surgery is also considered for those with ongoing infections, abnormal sinus structures, or growths. As a result, nonsurgical treatments, such as medications to reduce inflammation and improve drainage, are widely popular.
OPPORTUNITY: Growing demand for organ transplants and cell & gene therapy
AI in sinus surgeries marks a major advancement in otolaryngology, promising more effective and safer procedures. Robotic-assisted technology has revolutionized functional endoscopic sinus surgery (FESS) by providing greater precision and control. Integrating robotic systems into surgeries enhances surgeons' skills, enabling intricate maneuvers with accuracy. These platforms offer improved visualization and magnification, allowing detailed examination and precise targeting of diseased tissue. The robotic arms, equipped with specialized instruments, offer superior range of motion and flexibility compared to traditional tools.
CHALLENGE: Storage and transportation logistics
Many countries currently face a shortage of skilled professionals to perform ENT procedures effectively. FESS requires specialized training and skills that are not widely available, leading to a scarcity of qualified surgeons. This shortage is especially pronounced in emerging markets, where access to FESS is limited. In 2023, the U.S. had over 12,000 otolaryngologists but is projected to face a shortage of 2,500 by 2025 (Source: Pubmed.gov). Some low-income countries have fewer than one ENT specialist per million people. Underdeveloped regions face this issue on a larger scale. For example, a 2020 PubMed survey of 22 African countries found that Zambia had only three expatriate ENT surgeons, and Malawi had none, relying on occasional visits from foreign ENT surgeons. In 2023, Zimbabwe, with over 15 million people, had only four ENT surgeons. The primary cause of this problem is the shortage of ENT health personnel.
Functional Endoscopic Sinus Surgery Ecosystem
Prominent companies in this market include well-established, financially stable manufacturers of Functional endoscopic sinus surgery. These companies have been operating in the market for several years and possess diversified state-of-the-art technologies, product portfolios, and strong global sales and marketing networks. Prominent companies in this market include Medtronic plc (Ireland), Stryker Corporation (US), Olympus Corporation (Japan), B. Braun Melsungen Ag (Germany), and KARL STORZ (Germany).
In 2023, endoscopes segment to observe the highest growth rate of the functional endoscopic sinus surgery industry, by product.
The functional endoscopic sinus surgery market, by product, is segmented into endoscopes, surgical instruments, and navigation systems. The surgical instruments segment accounted for the largest market share in 2023. This is due to the growth in new surgical methods or techniques with improved set of instruments. The endoscopes segment to register highest CAGR during the forecast period. This is attributed to the increase in innovations in endoscopes technology such as 3D endoscopes.
In 2023, fungal sinusitis segment to dominate the Functional endoscopic sinus surgery industry, by indication
Based on indication, the functional endoscopic sinus surgery market is segmented into chronic sinusitis, recurrent sinusitis, nasal polyposis, fungal sinusitis, and other indications. The fungal sinusitis segment accounted for the largest market share in 2023. This can be attributed to the growing elderly population with weakened immune system and exposure of humans to indoor and outdoor fungal spores in the air and continuous inhalation of spores which gets deposited along the airway mucosa.
In 2023, hospitals & ASCs segment to dominate the Functional endoscopic sinus surgery industry, by end user.
Based on End user, the functional endoscopic sinus surgery market is segmented into hospitals & ASCs and specialty clinics. The hospitals & ASCs segment accounted for the largest market share in 2023. This is because ASCs manage a large volume of outpatient surgeries which gives patients a greater convenience and faster turnaround times. Also, reimbursement facilities favoring the patients will additionally aid into the market share of hospitals and ASCs.
In 2023, North America to dominate in Functional endoscopic sinus surgery industry.
The global Functional endoscopic sinus surgery market is segmented into North America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and GCC. North America is expected to dominate during the forecast period, primarily due to the growing availability of government funding for healthcare and R&D spending, number of patients for chronic sinusitis are on the rise, awareness programs during the World Sinus Health Awareness Month, and the presence of major players in the US.
To know about the assumptions considered for the study, download the pdf brochure
The Functional endoscopic sinus surgery market is dominated by players such as Medtronic plc (Ireland), Stryker Corporation (US), Olympus Corporation (Japan), B. Braun Melsungen Ag (Germany), and KARL STORZ (Germany).
Scope of the Functional Endoscopic Sinus Surgery Industry:
|
Report Metric |
Details |
|
Market Revenue in 2024 |
$1.2 billion |
|
Projected Revenue by 2029 |
$1.7 billion |
|
Revenue Rate |
Poised to Grow at a CAGR of 7.6% |
|
Market Driver |
High prevalence of chronic sinusitis |
|
Market Opportunity |
Growing demand for organ transplants and cell & gene therapy |
This research report categorizes the Functional endoscopic sinus surgery market to forecast revenue and analyze trends in each of the following submarkets:
By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
- GCC
By Product
- Endoscopes
- Surgical Instruments
- Navigation Systems
By Procedure
- Frontal Sinus Surgery
- Ethmoid Sinus Surgery
- Maxillary Sinus Surgery
- Sphenoid Sinus Surgery
- Other Procedures
By Indication
- Chronic Sinusitis
- Recurrent Sinusitis
- Nasal Polyposis
- Fungal Sinusitis
- Other Indications
By Patient Type
- Adult Patients
- Pediatric Patient
By End User
- Hospitals & Ambulatory Surgery Centres (ASCs)
- Specialty Clinics
Recent Developments of Functional Endoscopic Sinus Surgery Industry:
- In 2024, Integra acquired Acclarent, Inc., a pioneer in ENT surgical interventions. The addition of Acclarent’s innovative product portfolio expanded the breadth of Integra’s market-leading brands and provided immediate scale and accretive growth via a dedicated sales channel.
- In 2022, Medtronic completed the acquisition of Intersect ENT, expanding the company’s comprehensive ENT portfolio with innovative products used in sinus procedures to improve postoperative outcomes and treat nasal polyps.
- In 2022, Olympus Corporation (Japan) announced FDA clearance for its CELERIS single-use sinus debrider system.
Frequently Asked Questions (FAQ):
What is the projected market value of the global Functional endoscopic sinus surgery market?
The global market of Functional endoscopic sinus surgery is projected to reach USD 1.7 Billion by 2029
What is the estimated growth rate (CAGR) of the global Functional endoscopic sinus surgery market for the next five years?
The global Functional endoscopic sinus surgery market is projected to grow at a Compound Annual Growth Rate (CAGR) of 7.6% from 2024 to 2029. .
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
TABLE OF CONTENTS
1 INTRODUCTION (Page No. - 28)
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS
1.3 STUDY SCOPE
1.3.1 MARKETS COVERED
1.3.2 REGIONS COVERED
1.3.3 YEARS CONSIDERED
1.3.4 CURRENCY CONSIDERED
1.4 STAKEHOLDERS
2 RESEARCH METHODOLOGY (Page No. - 32)
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Breakdown of primary interviews
2.1.2.2 Breakdown of primary interviews
2.2 MARKET SIZE ESTIMATION
2.2.1 APPROACH 1: BOTTOM-UP APPROACH
2.2.1.1 Growth forecast
2.2.2 TOP-DOWN APPROACH
2.2.3 GEOGRAPHIC MARKET ASSESSMENT
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
2.4 MARKET SHARE ANALYSIS
2.5 STUDY ASSUMPTIONS
2.6 RISK ASSESSMENT
2.7 LIMITATIONS
3 EXECUTIVE SUMMARY (Page No. - 44)
4 PREMIUM INSIGHTS (Page No. - 48)
4.1 FUNCTIONAL ENDOSCOPIC SINUS SURGERY MARKET OVERVIEW
4.2 ASIA PACIFIC: FUNCTIONAL ENDOSCOPIC SINUS SURGERY INDUSTRY, BY PROCEDURE (2023)
4.3 REGIONAL GROWTH OPPORTUNITIES IN FUNCTIONAL ENDOSCOPIC SINUS SURGERY INDUSTRY
4.4 FUNCTIONAL ENDOSCOPIC SINUS SURGERY INDUSTRY: REGIONAL MIX
4.5 FUNCTIONAL ENDOSCOPIC SINUS SURGERY INDUSTRY: DEVELOPED MARKETS VS. EMERGING ECONOMIES
5 MARKET OVERVIEW (Page No. - 53)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 High prevalence of chronic sinusitis
5.2.1.2 Growing preference for MIS
5.2.1.3 Technological advancements
5.2.1.4 Rising awareness
5.2.2 RESTRAINTS
5.2.2.1 Risks associated with sinus surgeries
5.2.2.2 Availability of nonsurgical treatments for chronic sinusitis
5.2.2.3 High procedural costs
5.2.3 OPPORTUNITIES
5.2.3.1 Integration of AI and robotics in FESS
5.2.3.2 Growing healthcare market in emerging economies
5.2.4 CHALLENGES
5.2.4.1 Shortage of skilled professionals
5.2.5 TRENDS
5.2.5.1 Emergence of minimally invasive in-office sinus surgery
5.2.5.2 Increased use of artificial intelligence (AI)
5.2.5.3 Development of new surgical techniques
5.2.5.4 Personalized treatment plans
5.2.5.5 Improved patient outcomes
5.3 PRICING ANALYSIS
5.3.1 AVERAGE SELLING PRICE TREND OF FESS PRODUCTS
5.3.2 AVERAGE SELLING PRICE OF FESS PRODUCTS, BY REGION
5.4 PATENT ANALYSIS
5.4.1 LIST OF MAJOR PATENTS
5.5 VALUE CHAIN ANALYSIS
5.6 SUPPLY CHAIN ANALYSIS
5.7 ECOSYSTEM ANALYSIS
5.7.1 FUNCTIONAL ENDOSCOPIC SINUS SURGERY MARKET: ROLE IN ECOSYSTEM
5.8 PORTER’S FIVE FORCES ANALYSIS
5.8.1 THREAT OF NEW ENTRANTS
5.8.2 THREAT OF SUBSTITUTES
5.8.3 BARGAINING POWER OF SUPPLIERS
5.8.4 BARGAINING POWER OF BUYERS
5.8.5 INTENSITY OF COMPETITIVE RIVALRY
5.9 KEY STAKEHOLDERS AND BUYING CRITERIA
5.9.1 KEY STAKEHOLDERS IN BUYING PROCESS
5.9.2 BUYING CRITERIA
5.10 REGULATORY ANALYSIS
5.10.1 REGULATORY LANDSCAPE
5.10.1.1 US
5.10.1.2 Europe
5.10.1.3 India
5.10.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.11 TRADE ANALYSIS
5.12 TECHNOLOGY ANALYSIS
5.12.1 KEY TECHNOLOGIES
5.12.1.1 Endoscopes
5.12.1.2 Navigation systems
5.12.2 ADJACENT TECHNOLOGIES
5.12.2.1 Balloon sinus dilation devices
5.13 KEY CONFERENCES AND EVENTS IN 2024–2025
5.14 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
5.15 INVESTMENT AND FUNDING SCENARIO
5.16 IMPACT OF GENERATIVE AI ON FUNCTIONAL ENDOSCOPIC SINUS SURGERY INDUSTRY
6 FUNCTIONAL ENDOSCOPIC SINUS SURGERY MARKET, BY PRODUCT (Page No. - 81)
6.1 INTRODUCTION
6.2 SURGICAL INSTRUMENTS
6.2.1 SURGICAL INSTRUMENTS TO HOLD LARGEST MARKET SHARE
6.3 ENDOSCOPES
6.3.1 SINUSCOPES
6.3.1.1 Sinuscopes to hold largest share of FESS endoscopes market
6.3.2 RHINOSCOPES
6.3.2.1 Greater flexibility over sinuscopes to support market growth
6.4 NAVIGATION SYSTEMS
6.4.1 OPTICAL NAVIGATION SYSTEMS
6.4.2 ELECTROMAGNETIC NAVIGATION SYSTEMS
6.4.2.1 Advantageous over optical navigation systems to drive market
7 FUNCTIONAL ENDOSCOPIC SINUS SURGERY MARKET, BY PROCEDURE (Page No. - 100)
7.1 INTRODUCTION
7.2 MAXILLARY SINUS SURGERY
7.2.1 INVASIVE NATURE TO AFFECT ADOPTION OF MAXILLARY SINUS SURGERY
7.3 ETHMOID SINUS SURGERY
7.3.1 EFFECTIVENESS OF TREATMENT TO DRIVE ADOPTION
7.4 FRONTAL SINUS SURGERY
7.4.1 INCREASING PREVALENCE OF CHRONIC RHINOSINUSITIS TO DRIVE MARKET
7.5 SPHENOID SINUS SURGERY
7.5.1 HIGHER INDICATIONS FOR SURGERY TO BOOST ADOPTION
7.6 OTHER PROCEDURES
8 FUNCTIONAL ENDOSCOPIC SINUS SURGERY MARKET, BY INDICATION (Page No. - 114)
8.1 INTRODUCTION
8.2 FUNGAL SINUSITIS
8.2.1 RISING EXPOSURE TO FUNGAL SPORES TO DRIVE MARKET
8.3 CHRONIC SINUSITIS
8.3.1 GROWING PREVALENCE OF CRS TO SUPPORT MARKET GROWTH
8.4 NASAL POLYPOSIS
8.4.1 WIDE PREVALENCE OF CAUSATIVE/CONTRIBUTING FACTORS TO DRIVE MARKET
8.5 RECURRENT SINUSITIS
8.5.1 GROWING PREVALENCE OF COLD TO SUPPORT MARKET GROWTH
8.6 OTHER INDICATIONS
9 FUNCTIONAL ENDOSCOPIC SINUS SURGERY MARKET, BY PATIENT TYPE (Page No. - 128)
9.1 INTRODUCTION
9.2 ADULT PATIENTS
9.2.1 ADULT PATIENTS TO DOMINATE MARKET FOR FESS
9.3 PEDIATRIC PATIENTS
9.3.1 HIGH PREVALENCE OF SINUSITIS IN CHILDREN TO DRIVE MARKET
10 FUNCTIONAL ENDOSCOPIC SINUS SURGERY MARKET, BY END USER (Page No. - 135)
10.1 INTRODUCTION
10.2 HOSPITALS & AMBULATORY SURGERY CENTERS
10.2.1 HOSPITALS & ASCS TO FORM LARGEST AND FASTEST-GROWING END-USER SEGMENT
10.3 SPECIALTY CLINICS
10.3.1 FASTER RECOVERY TIME AND COST-EFFECTIVENESS TO SUPPORT GROWTH
11 FUNCTIONAL ENDOSCOPIC SINUS SURGERY MARKET, BY REGION (Page No. - 142)
11.1 INTRODUCTION
11.2 NORTH AMERICA
11.2.1 US
11.2.1.1 US to dominate North American market
11.2.2 CANADA
11.2.2.1 Rising geriatric population and associated increase in prevalence of CRS to support market growth
11.3 EUROPE
11.3.1 GERMANY
11.3.1.1 Germany to hold largest market share in Europe
11.3.2 UK
11.3.2.1 High R&D expenditure to drive market
11.3.3 FRANCE
11.3.3.1 High burden of chronic sinusitis to propel adoption of FESS
11.3.4 ITALY
11.3.4.1 Growing geriatric population to support adoption of FESS products
11.3.5 SPAIN
11.3.5.1 Rising healthcare expenditure to drive market for FESS
11.3.6 REST OF EUROPE
11.4 ASIA PACIFIC
11.4.1 CHINA
11.4.1.1 China to hold largest market share in APAC
11.4.2 JAPAN
11.4.2.1 Research initiatives to support market growth in Japan
11.4.3 INDIA
11.4.3.1 Increasing investments in research to support market growth
11.4.4 REST OF ASIA PACIFIC
11.5 LATIN AMERICA
11.5.1 BRAZIL
11.5.1.1 Brazil to hold largest share of LATAM market till 2029
11.5.2 MEXICO
11.5.2.1 Rising geriatric population to support market growth
11.5.3 REST OF LATIN AMERICA
11.6 MIDDLE EAST & AFRICA
11.6.1 RISING HEALTHCARE INVESTMENTS TO SUPPORT MARKET GROWTH
11.7 GCC COUNTRIES
11.7.1 UAE
11.7.1.1 Growing number of hospitals to drive market
11.7.2 SAUDI ARABIA
11.7.2.1 Healthcare infrastructural improvements to support market growth
11.7.3 OTHER GCC COUNTRIES
12 COMPETITIVE LANDSCAPE (Page No. - 215)
12.1 OVERVIEW
12.2 KEY PLAYER STRATEGY/RIGHT TO WIN
12.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN FUNCTIONAL ENDOSCOPIC SINUS SURGERY INDUSTRY
12.3 REVENUE ANALYSIS
12.4 MARKET SHARE ANALYSIS
12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
12.5.1 STARS
12.5.2 EMERGING LEADERS
12.5.3 PERVASIVE PLAYERS
12.5.4 PARTICIPANTS
12.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
12.5.5.1 Company footprint
12.5.5.2 Product footprint
12.5.5.3 Regional footprint
12.5.5.4 Procedure footprint
12.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
12.6.1 PROGRESSIVE COMPANIES
12.6.2 RESPONSIVE COMPANIES
12.6.3 DYNAMIC COMPANIES
12.6.4 STARTING BLOCKS
12.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
12.7 VALUATION & FINANCIAL METRICS
12.8 BRAND/PRODUCT COMPARISON
12.9 COMPETITIVE SCENARIO
12.9.1 PRODUCT LAUNCHES & APPROVALS
12.9.2 DEALS
12.9.3 EXPANSIONS
13 COMPANY PROFILES (Page No. - 229)
13.1 KEY PLAYERS
13.1.1 MEDTRONIC PLC
13.1.1.1 Business overview
13.1.1.2 Products offered
13.1.1.3 Recent developments
13.1.1.3.1 Deals
13.1.1.4 MnM view
13.1.1.4.1 Right to win
13.1.1.4.2 Strategic choices
13.1.1.4.3 Weaknesses & competitive threats
13.1.2 STRYKER CORPORATION
13.1.2.1 Business overview
13.1.2.2 Products offered
13.1.2.3 Recent developments
13.1.2.3.1 Expansions
13.1.2.4 MnM view
13.1.2.4.1 Right to win
13.1.2.4.2 Strategic choices
13.1.2.4.3 Weaknesses & competitive threats
13.1.3 OLYMPUS CORPORATION
13.1.3.1 Business overview
13.1.3.2 Products offered
13.1.3.3 Recent developments
13.1.3.3.1 Product approvals
13.1.3.4 MnM view
13.1.3.4.1 Right to win
13.1.3.4.2 Strategic choices
13.1.3.4.3 Weaknesses & competitive threats
13.1.4 B. BRAUN MELSUNGEN AG
13.1.4.1 Business overview
13.1.4.2 Products offered
13.1.5 KARL STORZ
13.1.5.1 Business overview
13.1.5.2 Products offered
13.1.6 CONMED CORPORATION
13.1.6.1 Business overview
13.1.6.2 Products offered
13.1.7 TELEFLEX INCORPORATED
13.1.7.1 Business overview
13.1.7.2 Products offered
13.1.8 INTEGRA LIFESCIENCES
13.1.8.1 Business overview
13.1.8.2 Products offered
13.1.8.3 Recent developments
13.1.8.3.1 Deals
13.1.9 BRAINLAB AG
13.1.9.1 Business overview
13.1.9.2 Products offered
13.1.10 RUDOLF MEDICAL GMBH + CO. KG
13.1.10.1 Business overview
13.1.10.2 Products offered
13.2 OTHER PLAYERS
13.2.1 ATMOS MEDIZINTECHNIK
13.2.2 INNOVIA MEDICAL
13.2.3 SUTTER MEDIZINTECHNIK GMBH
13.2.4 RZ MEDIZINTECHNIK
13.2.5 ADVIN HEALTHCARE
13.2.6 ECLERIS
13.2.7 HENKE SASS WOLF
13.2.8 JEDMED
13.2.9 ENTERMED
13.2.10 FIAGON GMBH
13.2.11 CLARONAV KOLAHI INC.
13.2.12 ADEPT MEDICAL
13.2.13 MEDELEC SURGICAL
13.2.14 HEAL FORCE BIO-MEDITECH HOLDINGS LIMITED
13.2.15 COLLIN MEDICAL
14 APPENDIX (Page No. - 265)
14.1 DISCUSSION GUIDE
14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
14.3 CUSTOMIZATION OPTIONS
14.4 RELATED REPORTS
14.5 AUTHOR DETAILS
LIST OF TABLES (356 TABLES)
TABLE 1 FUNCTIONAL ENDOSCOPIC SINUS SURGERY MARKET: INCLUSIONS AND EXCLUSIONS
TABLE 2 KEY DATA FROM PRIMARY SOURCES
TABLE 3 AVERAGE SELLING PRICE TREND OF FESS PRODUCTS, BY TYPE, 2021–2023
TABLE 4 AVERAGE SELLING PRICE OF FESS PRODUCTS, BY REGION (2023)
TABLE 5 FUNCTIONAL ENDOSCOPIC SINUS SURGERY INDUSTRY: PORTER’S FIVE FORCES ANALYSIS
TABLE 6 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY END USER
TABLE 7 KEY BUYING CRITERIA FOR FUNCTIONAL ENDOSCOPIC SINUS SURGERY PRODUCTS
TABLE 8 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 9 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 10 LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 11 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 12 EXPORT DATA FOR HS CODE 901890, BY COUNTRY, 2019–2023 (USD MILLION)
TABLE 13 IMPORT DATA FOR HS CODE 901890, BY COUNTRY, 2019–2023 (USD MILLION)
TABLE 14 MARKET: DETAILED LIST OF KEY CONFERENCES AND EVENTS (2024–2025)
TABLE 15 MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 16 SURGICAL INSTRUMENTS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 17 NORTH AMERICA: SURGICAL INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 18 EUROPE: SURGICAL INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 19 ASIA PACIFIC: SURGICAL INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 20 LATIN AMERICA: SURGICAL INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 21 GCC COUNTRIES: SURGICAL INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 22 ENDOSCOPES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 23 ENDOSCOPES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 24 NORTH AMERICA: ENDOSCOPES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 25 EUROPE: ENDOSCOPES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 26 ASIA PACIFIC: ENDOSCOPES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 27 LATIN AMERICA: ENDOSCOPES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 28 GCC COUNTRIES: ENDOSCOPES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 29 SINUSCOPES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 30 NORTH AMERICA: SINUSCOPES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 31 EUROPE: SINUSCOPES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 32 ASIA PACIFIC: SINUSCOPES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 33 LATIN AMERICA: SINUSCOPES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 34 GCC COUNTRIES: SINUSCOPES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 35 RHINOSCOPES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 36 NORTH AMERICA: RHINOSCOPES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 37 EUROPE: RHINOSCOPES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 38 ASIA PACIFIC: RHINOSCOPES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 39 LATIN AMERICA: RHINOSCOPES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 40 GCC COUNTRIES: RHINOSCOPES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 41 NAVIGATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 42 NAVIGATION SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 43 NORTH AMERICA: NAVIGATION SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 44 EUROPE: NAVIGATION SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 45 ASIA PACIFIC: NAVIGATION SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 46 LATIN AMERICA: NAVIGATION SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 47 GCC COUNTRIES: NAVIGATION SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 48 OPTICAL NAVIGATION SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 49 NORTH AMERICA: OPTICAL NAVIGATION SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 50 EUROPE: OPTICAL NAVIGATION SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 51 ASIA PACIFIC: OPTICAL NAVIGATION SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 52 LATIN AMERICA: OPTICAL NAVIGATION SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 53 GCC COUNTRIES: OPTICAL NAVIGATION SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 54 ELECTROMAGNETIC NAVIGATION SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 55 NORTH AMERICA: ELECTROMAGNETIC NAVIGATION SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 56 EUROPE: ELECTROMAGNETIC NAVIGATION SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 57 ASIA PACIFIC: ELECTROMAGNETIC NAVIGATION SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 58 LATIN AMERICA: ELECTROMAGNETIC NAVIGATION SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 59 GCC COUNTRIES: ELECTROMAGNETIC NAVIGATION SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 60 FUNCTIONAL ENDOSCOPIC SINUS SURGERY MARKET, BY PROCEDURE, 2022–2029 (USD MILLION)
TABLE 61 MAXILLARY SINUS SURGERY MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 62 NORTH AMERICA: MAXILLARY SINUS SURGERY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 63 EUROPE: MAXILLARY SINUS SURGERY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 64 ASIA PACIFIC: MAXILLARY SINUS SURGERY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 65 LATIN AMERICA: MAXILLARY SINUS SURGERY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 66 GCC COUNTRIES: MAXILLARY SINUS SURGERY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 67 ETHMOID SINUS SURGERY MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 68 NORTH AMERICA: ETHMOID SINUS SURGERY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 69 EUROPE: ETHMOID SINUS SURGERY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 70 ASIA PACIFIC: ETHMOID SINUS SURGERY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 71 LATIN AMERICA: ETHMOID SINUS SURGERY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 72 GCC COUNTRIES: ETHMOID SINUS SURGERY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 73 FRONTAL SINUS SURGERY MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 74 NORTH AMERICA: FRONTAL SINUS SURGERY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 75 EUROPE: FRONTAL SINUS SURGERY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 76 ASIA PACIFIC: FRONTAL SINUS SURGERY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 77 LATIN AMERICA: FRONTAL SINUS SURGERY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 78 GCC COUNTRIES: FRONTAL SINUS SURGERY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 79 SPHENOID SINUS SURGERY MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 80 NORTH AMERICA: SPHENOID SINUS SURGERY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 81 EUROPE: SPHENOID SINUS SURGERY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 82 ASIA PACIFIC: SPHENOID SINUS SURGERY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 83 LATIN AMERICA: SPHENOID SINUS SURGERY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 84 GCC COUNTRIES: SPHENOID SINUS SURGERY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 85 OTHER FESS PROCEDURES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 86 NORTH AMERICA: OTHER FESS PROCEDURES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 87 EUROPE: OTHER FESS PROCEDURES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 88 ASIA PACIFIC: OTHER FESS PROCEDURES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 89 LATIN AMERICA: OTHER FESS PROCEDURES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 90 GCC COUNTRIES: OTHER FESS PROCEDURES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 91 FUNCTIONAL ENDOSCOPIC SINUS SURGERY MARKET, BY INDICATION, 2022–2029 (USD MILLION)
TABLE 92 FUNCTIONAL ENDOSCOPIC SINUS SURGERY INDUSTRY FOR FUNGAL SINUSITIS, BY REGION, 2022–2029 (USD MILLION)
TABLE 93 NORTH AMERICA: MARKET FOR FUNGAL SINUSITIS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 94 EUROPE: MARKET FOR FUNGAL SINUSITIS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 95 ASIA PACIFIC: MARKET FOR FUNGAL SINUSITIS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 96 LATIN AMERICA: MARKET FOR FUNGAL SINUSITIS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 97 GCC COUNTRIES: MARKET FOR FUNGAL SINUSITIS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 98 MARKET FOR CHRONIC SINUSITIS, BY REGION, 2022–2029 (USD MILLION)
TABLE 99 NORTH AMERICA: MARKET FOR CHRONIC SINUSITIS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 100 EUROPE: MARKET FOR CHRONIC SINUSITIS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 101 ASIA PACIFIC: MARKET FOR CHRONIC SINUSITIS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 102 LATIN AMERICA: MARKET FOR CHRONIC SINUSITIS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 103 GCC COUNTRIES: MARKET FOR CHRONIC SINUSITIS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 104 MARKET FOR NASAL POLYPOSIS, BY REGION, 2022–2029 (USD MILLION)
TABLE 105 NORTH AMERICA: MARKET FOR NASAL POLYPOSIS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 106 EUROPE: MARKET FOR NASAL POLYPOSIS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 107 ASIA PACIFIC: MARKET FOR NASAL POLYPOSIS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 108 LATIN AMERICA: MARKET FOR NASAL POLYPOSIS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 109 GCC COUNTRIES: MARKET FOR NASAL POLYPOSIS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 110 FUNCTIONAL ENDOSCOPIC SINUS SURGERY MARKET FOR RECURRENT SINUSITIS, BY REGION, 2022–2029 (USD MILLION)
TABLE 111 NORTH AMERICA: MARKET FOR RECURRENT SINUSITIS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 112 EUROPE: MARKET FOR RECURRENT SINUSITIS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 113 ASIA PACIFIC: MARKET FOR RECURRENT SINUSITIS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 114 LATIN AMERICA: MARKET FOR RECURRENT SINUSITIS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 115 GCC COUNTRIES: MARKET FOR RECURRENT SINUSITIS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 116 MARKET FOR OTHER INDICATIONS, BY REGION, 2022–2029 (USD MILLION)
TABLE 117 NORTH AMERICA: MARKET FOR OTHER INDICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 118 EUROPE: MARKET FOR OTHER INDICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 119 ASIA PACIFIC: MARKET FOR OTHER INDICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 120 LATIN AMERICA: MARKET FOR OTHER INDICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 121 GCC COUNTRIES: MARKET FOR OTHER INDICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 122 MARKET, BY PATIENT TYPE, 2022–2029 (USD MILLION)
TABLE 123 MARKET FOR ADULT PATIENTS, BY REGION, 2022–2029 (USD MILLION)
TABLE 124 NORTH AMERICA: MARKET FOR ADULT PATIENTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 125 EUROPE: MARKET FOR ADULT PATIENTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 126 ASIA PACIFIC: MARKET FOR ADULT PATIENTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 127 LATIN AMERICA: MARKET FOR ADULT PATIENTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 128 GCC COUNTRIES: MARKET FOR ADULT PATIENTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 129 FUNCTIONAL ENDOSCOPIC SINUS SURGERY MARKET FOR PEDIATRIC PATIENTS, BY REGION, 2022–2029 (USD MILLION)
TABLE 130 NORTH AMERICA: MARKET FOR PEDIATRIC PATIENTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 131 EUROPE: MARKET FOR PEDIATRIC PATIENTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 132 ASIA PACIFIC: MARKET FOR PEDIATRIC PATIENTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 133 LATIN AMERICA: MARKET FOR PEDIATRIC PATIENTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 134 GCC COUNTRIES: MARKET FOR PEDIATRIC PATIENTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 135 MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 136 MARKET FOR HOSPITALS & AMBULATORY SURGERY CENTERS, BY REGION, 2022–2029 (USD MILLION)
TABLE 137 NORTH AMERICA: MARKET FOR HOSPITALS & AMBULATORY SURGERY CENTERS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 138 EUROPE: MARKET FOR HOSPITALS & AMBULATORY SURGERY CENTERS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 139 ASIA PACIFIC: MARKET FOR HOSPITALS & AMBULATORY SURGERY CENTERS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 140 LATIN AMERICA: MARKET FOR HOSPITALS & AMBULATORY SURGERY CENTERS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 141 GCC COUNTRIES: MARKET FOR HOSPITALS & AMBULATORY SURGERY CENTERS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 142 MARKET FOR SPECIALTY CLINICS, BY REGION, 2022–2029 (USD MILLION)
TABLE 143 NORTH AMERICA: MARKET FOR SPECIALTY CLINICS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 144 EUROPE: MARKET FOR SPECIALTY CLINICS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 145 ASIA PACIFIC: MARKET FOR SPECIALTY CLINICS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 146 LATIN AMERICA: MARKET FOR SPECIALTY CLINICS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 147 GCC COUNTRIES: MARKET FOR SPECIALTY CLINICS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 148 FUNCTIONAL ENDOSCOPIC SINUS SURGERY MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 149 NORTH AMERICA: FUNCTIONAL ENDOSCOPIC SINUS SURGERY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 150 NORTH AMERICA: MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 151 NORTH AMERICA: ENDOSCOPES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 152 NORTH AMERICA: NAVIGATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 153 NORTH AMERICA: MARKET, BY PROCEDURE, 2022–2029 (USD MILLION)
TABLE 154 NORTH AMERICA: MARKET, BY INDICATION, 2022–2029 (USD MILLION)
TABLE 155 NORTH AMERICA: MARKET, BY PATIENT TYPE, 2022–2029 (USD MILLION)
TABLE 156 NORTH AMERICA: MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 157 US: FUNCTIONAL ENDOSCOPIC SINUS SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 158 US: ENDOSCOPES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 159 US: NAVIGATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 160 US: MARKET, BY PROCEDURE, 2022–2029 (USD MILLION)
TABLE 161 US: MARKET, BY INDICATION, 2022–2029 (USD MILLION)
TABLE 162 US: MARKET, BY PATIENT TYPE, 2022–2029 (USD MILLION)
TABLE 163 US: MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 164 US: MARKET FOR SINUS SURGERIES, 2022–2029 (PROCEDURES)
TABLE 165 CANADA: FUNCTIONAL ENDOSCOPIC SINUS SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 166 CANADA: ENDOSCOPES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 167 CANADA: NAVIGATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 168 CANADA: MARKET, BY PROCEDURE, 2022–2029 (USD MILLION)
TABLE 169 CANADA: MARKET, BY INDICATION, 2022–2029 (USD MILLION)
TABLE 170 CANADA: MARKET, BY PATIENT TYPE, 2022–2029 (USD MILLION)
TABLE 171 CANADA: MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 172 EUROPE: FUNCTIONAL ENDOSCOPIC SINUS SURGERY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 173 EUROPE: MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 174 EUROPE: ENDOSCOPES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 175 EUROPE: NAVIGATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 176 EUROPE: FUNCTIONAL ENDOSCOPIC SINUS SURGERY MARKET, BY PROCEDURE, 2022–2029 (USD MILLION)
TABLE 177 EUROPE: MARKET, BY INDICATION, 2022–2029 (USD MILLION)
TABLE 178 EUROPE: MARKET, BY PATIENT TYPE, 2022–2029 (USD MILLION)
TABLE 179 EUROPE: MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 180 GERMANY: FUNCTIONAL ENDOSCOPIC SINUS SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 181 GERMANY: ENDOSCOPES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 182 GERMANY: NAVIGATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 183 GERMANY: MARKET, BY PROCEDURE, 2022–2029 (USD MILLION)
TABLE 184 GERMANY: MARKET, BY INDICATION, 2022–2029 (USD MILLION)
TABLE 185 GERMANY: MARKET, BY PATIENT TYPE, 2022–2029 (USD MILLION)
TABLE 186 GERMANY: MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 187 UK: FUNCTIONAL ENDOSCOPIC SINUS SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 188 UK: ENDOSCOPES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 189 UK: NAVIGATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 190 UK: MARKET, BY PROCEDURE, 2022–2029 (USD MILLION)
TABLE 191 UK: MARKET, BY INDICATION, 2022–2029 (USD MILLION)
TABLE 192 UK: MARKET, BY PATIENT TYPE, 2022–2029 (USD MILLION)
TABLE 193 UK: MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 194 FRANCE: FUNCTIONAL ENDOSCOPIC SINUS SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 195 FRANCE: ENDOSCOPES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 196 FRANCE: NAVIGATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 197 FRANCE: MARKET, BY PROCEDURE, 2022–2029 (USD MILLION)
TABLE 198 FRANCE: MARKET, BY INDICATION, 2022–2029 (USD MILLION)
TABLE 199 FRANCE: MARKET, BY PATIENT TYPE, 2022–2029 (USD MILLION)
TABLE 200 FRANCE: MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 201 ITALY: FUNCTIONAL ENDOSCOPIC SINUS SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 202 ITALY: ENDOSCOPES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 203 ITALY: NAVIGATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 204 ITALY: MARKET, BY PROCEDURE, 2022–2029 (USD MILLION)
TABLE 205 ITALY: MARKET, BY INDICATION, 2022–2029 (USD MILLION)
TABLE 206 ITALY: MARKET, BY PATIENT TYPE, 2022–2029 (USD MILLION)
TABLE 207 ITALY: MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 208 SPAIN: FUNCTIONAL ENDOSCOPIC SINUS SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 209 SPAIN: ENDOSCOPES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 210 SPAIN: NAVIGATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 211 SPAIN: MARKET, BY PROCEDURE, 2022–2029 (USD MILLION)
TABLE 212 SPAIN: MARKET, BY INDICATION, 2022–2029 (USD MILLION)
TABLE 213 SPAIN: MARKET, BY PATIENT TYPE, 2022–2029 (USD MILLION)
TABLE 214 SPAIN: MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 215 REST OF EUROPE: FUNCTIONAL ENDOSCOPIC SINUS SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 216 REST OF EUROPE: ENDOSCOPES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 217 REST OF EUROPE: NAVIGATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 218 REST OF EUROPE: MARKET, BY PROCEDURE, 2022–2029 (USD MILLION)
TABLE 219 REST OF EUROPE: MARKET, BY INDICATION, 2022–2029 (USD MILLION)
TABLE 220 REST OF EUROPE: MARKET, BY PATIENT TYPE, 2022–2029 (USD MILLION)
TABLE 221 REST OF EUROPE: MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 222 ASIA PACIFIC: FUNCTIONAL ENDOSCOPIC SINUS SURGERY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 223 ASIA PACIFIC: MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 224 ASIA PACIFIC: ENDOSCOPES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 225 ASIA PACIFIC: NAVIGATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 226 ASIA PACIFIC: MARKET, BY PROCEDURE, 2022–2029 (USD MILLION)
TABLE 227 ASIA PACIFIC: MARKET, BY INDICATION, 2022–2029 (USD MILLION)
TABLE 228 ASIA PACIFIC: MARKET, BY PATIENT TYPE, 2022–2029 (USD MILLION)
TABLE 229 ASIA PACIFIC: MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 230 CHINA: FUNCTIONAL ENDOSCOPIC SINUS SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 231 CHINA: ENDOSCOPES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 232 CHINA: NAVIGATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 233 CHINA: MARKET, BY PROCEDURE, 2022–2029 (USD MILLION)
TABLE 234 CHINA: MARKET, BY INDICATION, 2022–2029 (USD MILLION)
TABLE 235 CHINA: MARKET, BY PATIENT TYPE, 2022–2029 (USD MILLION)
TABLE 236 CHINA: MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 237 JAPAN: FUNCTIONAL ENDOSCOPIC SINUS SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 238 JAPAN: ENDOSCOPES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 239 JAPAN: NAVIGATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 240 JAPAN: MARKET, BY PROCEDURE, 2022–2029 (USD MILLION)
TABLE 241 JAPAN: MARKET, BY INDICATION, 2022–2029 (USD MILLION)
TABLE 242 JAPAN: MARKET, BY PATIENT TYPE, 2022–2029 (USD MILLION)
TABLE 243 JAPAN: MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 244 INDIA: FUNCTIONAL ENDOSCOPIC SINUS SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 245 INDIA: ENDOSCOPES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 246 INDIA: NAVIGATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 247 INDIA: MARKET, BY PROCEDURE, 2022–2029 (USD MILLION)
TABLE 248 INDIA: MARKET, BY INDICATION, 2022–2029 (USD MILLION)
TABLE 249 INDIA: MARKET, BY PATIENT TYPE, 2022–2029 (USD MILLION)
TABLE 250 INDIA: MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 251 REST OF ASIA PACIFIC: FUNCTIONAL ENDOSCOPIC SINUS SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 252 REST OF ASIA PACIFIC: ENDOSCOPES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 253 REST OF ASIA PACIFIC: NAVIGATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 254 REST OF ASIA PACIFIC: MARKET, BY PROCEDURE, 2022–2029 (USD MILLION)
TABLE 255 REST OF ASIA PACIFIC: MARKET, BY INDICATION, 2022–2029 (USD MILLION)
TABLE 256 REST OF ASIA PACIFIC: MARKET, BY PATIENT TYPE, 2022–2029 (USD MILLION)
TABLE 257 REST OF ASIA PACIFIC: MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 258 LATIN AMERICA: FUNCTIONAL ENDOSCOPIC SINUS SURGERY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 259 LATIN AMERICA: MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 260 LATIN AMERICA: ENDOSCOPES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 261 LATIN AMERICA: NAVIGATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 262 LATIN AMERICA: MARKET, BY PROCEDURE, 2022–2029 (USD MILLION)
TABLE 263 LATIN AMERICA: MARKET, BY INDICATION, 2022–2029 (USD MILLION)
TABLE 264 LATIN AMERICA: MARKET, BY PATIENT TYPE, 2022–2029 (USD MILLION)
TABLE 265 LATIN AMERICA: MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 266 BRAZIL: FUNCTIONAL ENDOSCOPIC SINUS SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 267 BRAZIL: ENDOSCOPES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 268 BRAZIL: NAVIGATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 269 BRAZIL: MARKET, BY PROCEDURE, 2022–2029 (USD MILLION)
TABLE 270 BRAZIL: MARKET, BY INDICATION, 2022–2029 (USD MILLION)
TABLE 271 BRAZIL: MARKET, BY PATIENT TYPE, 2022–2029 (USD MILLION)
TABLE 272 BRAZIL: MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 273 MEXICO: FUNCTIONAL ENDOSCOPIC SINUS SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 274 MEXICO: ENDOSCOPES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 275 MEXICO: NAVIGATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 276 MEXICO: MARKET, BY PROCEDURE, 2022–2029 (USD MILLION)
TABLE 277 MEXICO: MARKET, BY INDICATION, 2022–2029 (USD MILLION)
TABLE 278 MEXICO: MARKET, BY PATIENT TYPE, 2022–2029 (USD MILLION)
TABLE 279 MEXICO: MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 280 REST OF LATIN AMERICA: FUNCTIONAL ENDOSCOPIC SINUS SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 281 REST OF LATIN AMERICA: ENDOSCOPES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 282 REST OF LATIN AMERICA: NAVIGATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 283 REST OF LATIN AMERICA: MARKET, BY PROCEDURE, 2022–2029 (USD MILLION)
TABLE 284 REST OF LATIN AMERICA: MARKET, BY INDICATION, 2022–2029 (USD MILLION)
TABLE 285 REST OF LATIN AMERICA: MARKET, BY PATIENT TYPE, 2022–2029 (USD MILLION)
TABLE 286 REST OF LATIN AMERICA: MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 287 MIDDLE EAST & AFRICA: FUNCTIONAL ENDOSCOPIC SINUS SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 288 MIDDLE EAST & AFRICA: ENDOSCOPES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 289 MIDDLE EAST & AFRICA: NAVIGATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 290 MIDDLE EAST & AFRICA: MARKET, BY PROCEDURE, 2022–2029 (USD MILLION)
TABLE 291 MIDDLE EAST & AFRICA: MARKET, BY INDICATION, 2022–2029 (USD MILLION)
TABLE 292 MIDDLE EAST & AFRICA: MARKET, BY PATIENT TYPE, 2022–2029 (USD MILLION)
TABLE 293 MIDDLE EAST & AFRICA: MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 294 GCC COUNTRIES: FUNCTIONAL ENDOSCOPIC SINUS SURGERY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 295 GCC COUNTRIES: MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 296 GCC COUNTRIES: ENDOSCOPES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 297 GCC COUNTRIES: NAVIGATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 298 GCC COUNTRIES: MARKET, BY PROCEDURE, 2022–2029 (USD MILLION)
TABLE 299 GCC COUNTRIES: MARKET, BY INDICATION, 2022–2029 (USD MILLION)
TABLE 300 GCC COUNTRIES: MARKET, BY PATIENT TYPE, 2022–2029 (USD MILLION)
TABLE 301 GCC COUNTRIES: MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 302 UAE: FUNCTIONAL ENDOSCOPIC SINUS SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 303 UAE: ENDOSCOPES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 304 UAE: NAVIGATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 305 UAE: MARKET, BY PROCEDURE, 2022–2029 (USD MILLION)
TABLE 306 UAE: MARKET, BY INDICATION, 2022–2029 (USD MILLION)
TABLE 307 UAE: MARKET, BY PATIENT TYPE, 2022–2029 (USD MILLION)
TABLE 308 UAE: MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 309 SAUDI ARABIA: FUNCTIONAL ENDOSCOPIC SINUS SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 310 SAUDI ARABIA: ENDOSCOPES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 311 SAUDI ARABIA: NAVIGATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 312 SAUDI ARABIA: MARKET, BY PROCEDURE, 2022–2029 (USD MILLION)
TABLE 313 SAUDI ARABIA: MARKET, BY INDICATION, 2022–2029 (USD MILLION)
TABLE 314 SAUDI ARABIA: MARKET, BY PATIENT TYPE, 2022–2029 (USD MILLION)
TABLE 315 SAUDI ARABIA: MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 316 OTHER GCC COUNTRIES: FUNCTIONAL ENDOSCOPIC SINUS SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 317 OTHER GCC COUNTRIES: ENDOSCOPES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 318 OTHER GCC COUNTRIES: NAVIGATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 319 OTHER GCC COUNTRIES: MARKET, BY PROCEDURE, 2022–2029 (USD MILLION)
TABLE 320 OTHER GCC COUNTRIES: MARKET, BY INDICATION, 2022–2029 (USD MILLION)
TABLE 321 OTHER GCC COUNTRIES: MARKET, BY PATIENT TYPE, 2022–2029 (USD MILLION)
TABLE 322 OTHER GCC COUNTRIES: MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 323 OVERVIEW OF STRATEGIES DEPLOYED BY KEY MANUFACTURING COMPANIES
TABLE 324 MARKET: DEGREE OF COMPETITION
TABLE 325 MARKET: PRODUCT FOOTPRINT
TABLE 326 MARKET: REGIONAL FOOTPRINT
TABLE 327 MARKET: PROCEDURE FOOTPRINT
TABLE 328 MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS
TABLE 329 MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS
TABLE 330 MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–JUNE 2024
TABLE 331 MARKET: DEALS, JANUARY 2021–JUNE 2024
TABLE 332 MARKET: EXPANSIONS, JANUARY 2021–JUNE 2024
TABLE 333 MEDTRONIC PLC: COMPANY OVERVIEW
TABLE 334 MEDTRONIC PLC: PRODUCTS OFFERED
TABLE 335 MEDTRONIC PLC: DEALS, JANUARY 2021–MARCH 2024
TABLE 336 STRYKER CORPORATION: COMPANY OVERVIEW
TABLE 337 STRYKER CORPORATION: PRODUCTS OFFERED
TABLE 338 STRYKER CORPORATION: EXPANSIONS
TABLE 339 OLYMPUS CORPORATION: COMPANY OVERVIEW
TABLE 340 OLYMPUS CORPORATION: PRODUCTS OFFERED
TABLE 341 OLYMPUS CORPORATION: PRODUCT APPROVALS, JANUARY 2021–MAY 2024
TABLE 342 B. BRAUN MELSUNGEN AG: COMPANY OVERVIEW
TABLE 343 B. BRAUN MELSUNGEN AG: PRODUCTS OFFERED
TABLE 344 KARL STORZ: COMPANY OVERVIEW
TABLE 345 KARL STORZ: PRODUCTS OFFERED
TABLE 346 CONMED CORPORATION: COMPANY OVERVIEW
TABLE 347 CONMED CORPORATION: PRODUCTS OFFERED
TABLE 348 TELEFLEX INCORPORATED: COMPANY OVERVIEW
TABLE 349 TELEFLEX INCORPORATED: PRODUCTS OFFERED
TABLE 350 INTEGRA LIFESCIENCES: COMPANY OVERVIEW
TABLE 351 INTEGRA LIFESCIENCES: PRODUCTS OFFERED
TABLE 352 INTEGRA LIFESCIENCES: DEALS, JANUARY 2021–MAY 2024
TABLE 353 BRAINLAB AG: COMPANY OVERVIEW
TABLE 354 BRAINLAB AG: PRODUCTS OFFERED
TABLE 355 RUDOLF MEDICAL GMBH + CO. KG: COMPANY OVERVIEW
TABLE 356 RUDOLF MEDICAL GMBH + CO. KG: PRODUCTS OFFERED
LIST OF FIGURES (49 FIGURES)
FIGURE 1 FUNCTIONAL ENDOSCOPIC SINUS SURGERY MARKET: RESEARCH DESIGN METHODOLOGY
FIGURE 2 PRIMARY SOURCES: SUPPLY AND DEMAND SIDE
FIGURE 3 KEY INDUSTRY INSIGHTS
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS: BY END USER, DESIGNATION, AND REGION
FIGURE 7 BOTTOM-UP APPROACH: REVENUE-BASED APPROACH
FIGURE 8 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
FIGURE 9 MARKET: TOP-DOWN APPROACH
FIGURE 10 DATA TRIANGULATION METHODOLOGY
FIGURE 11 MARKET, BY PRODUCT, 2024 VS. 2029 (USD BILLION)
FIGURE 12 MARKET, BY PROCEDURE, 2024 VS. 2029 (USD BILLION)
FIGURE 13 MARKET, BY INDICATION, 2024 VS. 2029 (USD BILLION)
FIGURE 14 MARKET, BY PATIENT TYPE, 2024 VS. 2029 (USD BILLION)
FIGURE 15 MARKET, BY END USER, 2024 VS. 2029 (USD BILLION)
FIGURE 16 GEOGRAPHICAL SNAPSHOT OF MARKET
FIGURE 17 GROWING PREFERENCE FOR MINIMALLY INVASIVE SURGERIES TO DRIVE MARKET GROWTH
FIGURE 18 MAXILLARY SINUS SURGERY SEGMENT ACCOUNTED FOR LARGEST SHARE IN 2023
FIGURE 19 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
FIGURE 20 ASIA PACIFIC MARKET TO WITNESS FASTEST GROWTH DURING FORECAST PERIOD
FIGURE 21 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH DURING FORECAST PERIOD
FIGURE 22 MARKET DYNAMICS
FIGURE 23 GROWTH IN CURRENT HEALTHCARE EXPENDITURE PER CAPITA IN BRICS COUNTRIES, 2020, 2025, 2030, AND 2035
FIGURE 24 PATENT ANALYSIS FOR FUNCTIONAL ENDOSCOPIC SINUS SURGERY (JANUARY 2014–DECEMBER 2023)
FIGURE 25 VALUE CHAIN ANALYSIS: MAJOR VALUE-ADDED DURING TECHNOLOGY PROVIDERS AND MANUFACTURING & ASSEMBLY PHASES
FIGURE 26 MARKET: SUPPLY CHAIN ANALYSIS
FIGURE 27 MARKET: ECOSYSTEM ANALYSIS
FIGURE 28 MARKET: KEY PLAYERS
FIGURE 29 MARKET: PORTER’S FIVE FORCES ANALYSIS
FIGURE 30 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY END USER
FIGURE 31 KEY BUYING CRITERIA FOR END USERS
FIGURE 32 REVENUE SHIFT IN FUNCTIONAL ENDOSCOPIC SINUS SURGERY
FIGURE 33 NORTH AMERICA: MARKET SNAPSHOT
FIGURE 34 ASIA PACIFIC: MARKET SNAPSHOT
FIGURE 35 REVENUE ANALYSIS OF KEY PLAYERS IN MARKET (2021–2023)
FIGURE 36 MARKET SHARE ANALYSIS OF KEY PLAYERS IN MARKET (2023)
FIGURE 37 MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
FIGURE 38 MARKET: COMPANY FOOTPRINT
FIGURE 39 MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
FIGURE 40 EV/EBITDA OF KEY VENDORS
FIGURE 41 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
FIGURE 42 MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
FIGURE 43 MEDTRONIC PLC: COMPANY SNAPSHOT (2023)
FIGURE 44 STRYKER CORPORATION: COMPANY SNAPSHOT (2023)
FIGURE 45 OLYMPUS CORPORATION: COMPANY SNAPSHOT (2023)
FIGURE 46 B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT (2023)
FIGURE 47 CONMED CORPORATION: COMPANY SNAPSHOT (2023)
FIGURE 48 TELEFLEX INCORPORATED: COMPANY SNAPSHOT (2023)
FIGURE 49 INTEGRA LIFESCIENCES: COMPANY SNAPSHOT (2023)
The objective of the study is to analyze the key market dynamics, such as drivers, opportunities, challenges, restraints, and key player strategies. To track company developments such as acquisitions, product launches, expansions, collaborations, agreements, and partnerships of the leading players, the competitive landscape of the Functional endoscopic sinus surgery market to analyze market players on various parameters within the broad categories of business and product strategy. Top-down and bottom-up approaches were used to estimate the market size. To estimate the market size of segments and subsegments, the market breakdown and data triangulation were used.
The four steps involved in estimating the market size are:
Collecting Secondary Data
The secondary research data collection process involves the usage of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B), annual reports, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Functional endoscopic sinus surgery market. A database of the key industry leaders was also prepared using secondary research.
Collecting Primary Data
The primary research data was conducted after acquiring knowledge about the Functional endoscopic sinus surgery market scenario through secondary research. A significant number of primary interviews were conducted with stakeholders from both the demand side (such as hospitals, ASCs, and specialty clinics) and supply side (such as included various industry experts, such as Directors, Chief X Officers (CXOs), Vice Presidents (VPs) from business development, marketing, and product development teams, product manufacturers, wholesalers, channel partners, and distributors) across major countries of North America, Europe, Asia Pacific, the Middle East & Africa, Latin America, and GCC. Approximately 40% of the primary interviews were conducted with stakeholders from the demand side, while those from the supply side accounted for the remaining 60%. Primary data for this report was collected through questionnaires, emails, and telephonic interviews.
A breakdown of the primary respondents is provided below:
Breakdown of Primary Participants:
Note 1: *Others include sales managers, marketing managers, and product managers.
Note 2: Tiers are defined based on a company’s total revenue as of 2023: Tier 1=> USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3=< USD 500 million.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
All major product manufacturers offering various Functional endoscopic sinus surgery were identified at the global/regional level. Revenue mapping was done for the major players and was extrapolated to arrive at the global market value of each type of segment. The market value Functional endoscopic sinus surgery market was also split into various segments and subsegments at the region and country level based on:
- Product mapping of various manufacturers for each type of Functional endoscopic sinus surgery market at the regional and country-level
- Relative adoption pattern of each Functional endoscopic sinus surgery market among key indication segments at the regional and/or country-level
- Detailed primary research to gather qualitative and quantitative information related to segments and subsegments at the regional and/or country level.
- Detailed secondary research to gauge the prevailing market trends at the regional and/or country level
Global Functional endoscopic sinus surgery Market Size: Bottom-Up Approach
To know about the assumptions considered for the study, Request for Free Sample Report
Global Functional endoscopic sinus surgery Market Size: Top Down Approach
Data Triangulation
After arriving at the overall market size—using the market size estimation processes—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the Functional endoscopic sinus surgery industry.
Market Definition
Functional endoscopic sinus surgery (FESS) is a minimally invasive, mucosal sparing surgical technique utilized to treat medically refractory chronic rhinosinusitis (CRS) with or without polyps or recurrent acute rhinosinusitis. Rigid endoscopes are employed to visualize the surgical field to achieve one or more of the following goals:
- Opening the paranasal sinuses to facilitate ventilation and drainage from the paranasal sinuses.
- To remove polyps and/or osteitic bony fragments to reduce the inflammatory load
- To enlarge the sinus ostia to achieve optimal instillation of topical therapies
- To obtain bacterial or fungal cultures and tissue for histopathology.
Key Stakeholders
- Senior Management
- Finance/Procurement Department
- Doctors/HCPs
- Otolaryngologist
- Rhinologists
Report Objectives
- To provide detailed information about the factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
- To define, describe, segment, and forecast the Functional endoscopic sinus surgery market by product, procedure, indication, patient type, end user, and region.
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
- To analyze micro markets with respect to individual growth trends, prospects, and contributions to the overall Functional endoscopic sinus surgery market
- To forecast the size of the Functional endoscopic sinus surgery market in five main regions along with their respective key countries, namely, North America, Europe, the Asia Pacific, Latin America, Middle East & Africa, and GCC.
- To profile key players in the Functional endoscopic sinus surgery market and comprehensively analyze their core competencies and market shares
- To track and analyze competitive developments, such as acquisitions; product launches; expansions; collaborations, agreements, & partnerships; and R&D activities of the leading players in the Functional endoscopic sinus surgery market.
- To benchmark players within the Functional endoscopic sinus surgery market using the Competitive Leadership Mapping framework, which analyzes market players on various parameters within the broad categories of business and product strategy
Available Customizations
MarketsandMarkets offers the following customizations for this market report:
- Additional country-level analysis of the Functional endoscopic sinus surgery market
- Profiling of additional market players (up to 5)
Product Analysis
- Product matrix, which provides a detailed comparison of the product portfolio of each company in the Functional endoscopic sinus surgery Market
Growth opportunities and latent adjacency in Functional Endoscopic Sinus Surgery Market